Please use this identifier to cite or link to this item: https://dspace.ctu.edu.vn/jspui/handle/123456789/54538
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNguyễn, Thị Kim Thu-
dc.contributor.authorNguyễn, Thị Thanh Hương-
dc.date.accessioned2021-06-08T08:04:12Z-
dc.date.available2021-06-08T08:04:12Z-
dc.date.issued2018-
dc.identifier.issn0866-7861-
dc.identifier.urihttps://dspace.ctu.edu.vn/jspui/handle/123456789/54538-
dc.description.abstractAt the National Hospital of Dermatology and Venereology (Hanoi, SRV), of the total 133 drug items in use, the item number of the 2017’ inventory was 110 (82.7%), those with remaining expiry time less than 03 months were 103, and only one (01) with 18-months' expiry time left. These proved reasonable, with Vital drugs in Group V. The inventory value was VND 4,125,446,633. By ABC analysis, A, B and C category items were found 17.3%; 19.1%; 63.6%, respectively, and as thus, accounted for 79.5%; 15.3%; 5.2% of the hospital annual drug expenditure. The drug of the highest annual consumption value was Remicade (14.41% of the total value of A items), and Gastropulgite (of the A items list) took a value of 97.696 million VND. The main portion of the inventory was the drugs ofE Group (88.2% in item number, 98.2% in the drug expenditure). It was reasonable that none drug of D group (not essential, but desirably available) was inventoried, and unreasonable that Calcium Chloride and Neostigmine (as essential drugs of V group) were out of stock at the time of the survey.vi_VN
dc.language.isovivi_VN
dc.relation.ispartofseriesTạp chí Dược học;Số 506 .- Tr.2-4-
dc.subjectHospital of Dermatology and Venereologyvi_VN
dc.subjectABC-VED analysisvi_VN
dc.subjectInventoryvi_VN
dc.titleKhảo sát thực trạng thuốc tồn kho tại Bệnh viện Da liễu Trung ương năm 2017vi_VN
dc.typeArticlevi_VN
Appears in Collections:Dược học

Files in This Item:
File Description SizeFormat 
_file_
  Restricted Access
2.32 MBAdobe PDF
Your IP: 18.118.137.67


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.